Shares of Bicara Therapeutics rose sharply in premarket trading Monday after the clinical-stage biopharmaceutical company won U.S. Food and Drug Administration breakthrough-therapy designation for its ...
InvestorsHub on MSN
Bicara Therapeutics Inc. Shares Surge After FDA Grants Breakthrough Therapy Designation
Shares of Bicara Therapeutics Inc. (NASDAQ:BCAX) jumped 9.4% in Monday premarket trading after the company announced that its ...
Spruce Biosciences shares reached a 52-week high after a drug update and favorable comments on X by Martin Shkreli. Spruce said the Food and Drug Administration granted Breakthrough Therapy ...
HCW Biologics Inc. HCWB shares were up Monday after the company announced a breakthrough in developing second-generation pembrolizumab-based immunotherapies for solid tumors. What to Know: The company ...
The FDA granted Breakthrough Therapy designation based on clinical evidence from Part A of the REVEAL Phase 1/2 trials, which ...
Spruce Bioscience (Nasdaq: SPRB) shares soared by 1,378% on Monday to $130.40 (£97). The stock is up another 82% during ...
A tailwind from the artificial intelligence (AI) boom, along with an apparent breakthrough in quantum computing, helped push ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback